In light of yesterday's refusal by the U.S. Supreme Court to hear a case that could have prohibited further government funding of embryonic stem cell research on ethical grounds, a sigh of relief was expressed by many leaders in the field.
Doug Melton, co-director of the Harvard Stem Cell Institute , said, "We couldn't be happier that this frivolous, but at the same time potentially devastating distraction is behind us, and we can once again focus all our attention on advancing all forms of stem cell science, including research using embryonic stem cells -- which are the gold standard against which we measure other types." |